Recent Advancements in the Development of Heterocyclic Scaffolds as Potential Anti-cancer Agents Targeting EGFR and VEGFR-2.
- DOI
- 10.2174/0113895575448398260627111537
- Published
- 2026 Jun 30
- Container
- Mini reviews in medicinal chemistry
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.2174/0113895575448398260627111537,
title = {Recent Advancements in the Development of Heterocyclic Scaffolds as Potential Anti-cancer Agents Targeting EGFR and VEGFR-2.},
author = {Aggarwal V and Sharma S and Mishra A and Jahan N and Sharma T and Kumar S},
year = {2026},
journal = {Mini reviews in medicinal chemistry},
doi = {10.2174/0113895575448398260627111537},
url = {https://doi.org/10.2174/0113895575448398260627111537}
}RIS
TY - JOUR TI - Recent Advancements in the Development of Heterocyclic Scaffolds as Potential Anti-cancer Agents Targeting EGFR and VEGFR-2. AU - Aggarwal V AU - Sharma S AU - Mishra A AU - Jahan N AU - Sharma T AU - Kumar S PY - 2026 JO - Mini reviews in medicinal chemistry DO - 10.2174/0113895575448398260627111537 UR - https://doi.org/10.2174/0113895575448398260627111537 ER -
APA
V, A., S, S., A, M., N, J., T, S., & S, K. (2026). Recent Advancements in the Development of Heterocyclic Scaffolds as Potential Anti-cancer Agents Targeting EGFR and VEGFR-2.. Mini reviews in medicinal chemistry. https://doi.org/10.2174/0113895575448398260627111537
Source records
- pubmed · retrieved 2026-09-27T12:09:51.311Z
- europe-pmc · retrieved 2026-09-27T12:09:51.326Z